Cipla launches India’s first pneumotach-based wireless spirometer

Mumbai-based Cipla has announced the launch of Spirofy, India’s first pneumotach-based portable, wireless spirometer. With the launch, the company intends to revolutionise Obstructive Airway Disease (OAD) diagnosis, in line with its ambition to strengthen its position as the lung leader in India. Cipla’s Spirofy is a result of five years of in-house research by the Integrated Product Development (IPD) team, and it aims to transform OAD diagnosis in India. This advanced device ensures high result accuracy and individual patient safety using Bacterial Viral Filters. Spirofy is entirely wireless with good battery backup, making it suitable for use in outdoor camps, remote areas with power shortages, or simply providing physicians’ flexibility and ease of use. The device generates reports in real-time, which can be printed using a portable wireless thermal printer instantly, or a pdf version can be shared on the phone. Cipla will undertake the training of physicians in the interpretation of spirometry results.